You have 9 free searches left this month | for more free features.

City

Bethesda (2)

Condition

Neuroendocrine Neoplasms (2)

Neuroendocrine Tumors (2)

Gastroenteropancreatico Tumors (1)

Paraganglioma (1)

Pheochromocytoma (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

National Cancer Institute (NCI) (2)

Collaborator

Intervention

lu-177-dotatate (2)

amino acid infusion (1)

amino acid solution (1)

f-18-fdg (1)

fdg-pet scanning (1)

ga dotatate scanning (1)

ga-68-dotatate (1)

olaparib (1)

Study Documents

Intervention Type

drug (2)

diagnostic test (1)

Funder Type

NIH (2)

Study Type

Interventional (2)

lu-177-dotatate

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Pheochromocytoma, Paraganglioma, Neuroendocrine Tumors Trial run by the NCI (Lu-177-DOTATATE, Ga-68-DOTATATE, F-18-FDG)

Recruiting

Pheochromocytoma
+3 more

Lu-177-DOTATATE
+3 more

Bethesda, Maryland

National Institutes of Health Clinical Center

Jan 19, 2023

Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

Recruiting

Gastroenteropancreatico Tumors
+2 more

Lu-177-DOTATATE
+4 more

Bethesda, Maryland

National Institutes of Health Clinical Center

Jan 19, 2023